A. E. Roberts, J. E. Allanson, M. Tartaglia, and B. D. Gelb, Noonan syndrome, Lancet, vol.381, pp.333-375, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00562941

A. M. Turner and . Noonan-syndrome, J Paediatr Child Health, vol.50, pp.14-20, 2014.

A. A. Romano, J. E. Allanson, J. Dahlgren, B. D. Gelb, B. Hall et al., Noonan syndrome: clinical features, diagnosis, and management guidelines, Pediatrics, vol.126, pp.746-59, 2010.

I. Van-der-burgt, E. Berends, E. Lommen, S. Van-beersum, B. Hamel et al., Clinical and molecular studies in a large Dutch family with Noonan syndrome, Am J Med Genet, vol.53, pp.187-91, 1994.

M. Zenker, Genetic and pathogenetic aspects of Noonan syndrome and related disorders, Horm Res, vol.72, pp.57-63, 2009.

J. E. Allanson, A. Bohring, H. Dörr, A. Dufke, G. Gillessen-kaesbach et al., The face of Noonan syndrome: does phenotype predict genotype, Am J Med Genet A, vol.152, pp.1960-1966, 2010.

V. Bhambhani, M. Muenke, and . Noonan-syndrome, Am Fam Physician, vol.89, pp.37-43, 2014.

A. Malaquias, A. C. , I. A. Mendonca, and B. B. , Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/ MAPK pathway, Horm Res, vol.71, pp.185-93, 2009.

Y. Narumi, Y. Aoki, T. Niihori, M. Sakurai, H. Cavé et al., Clinical manifestations in patients with SOS1 mutations range from Noonan syndrome to CFC syndrome, J Hum Genet, vol.53, pp.834-875, 2008.

M. Tartaglia, G. Zampino, and B. D. Gelb, Noonan syndrome: clinical aspects and molecular pathogenesis, Mol Syndromol, vol.1, pp.2-26, 2010.

S. Nshuti, C. Hategekimana, A. Uwineza, J. Hitayezu, J. Mucumbitsi et al., Patients with Noonan Syndrome phenotype : spectrum of clinical features and congenital heart defect, Rwanda Medical Journal, vol.68, pp.26-31, 2010.

M. Tumurkhuu, M. Saitoh, A. Sato, K. Takahashi, M. Mimaki et al., Comprehensive genetic analysis of overlapping syndromes of RAS/RAF/ MEK/ERK pathway, Pediatr Int, vol.52, pp.557-62, 2010.

B. D. Gelb and M. Tartaglia, Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction, Hum Mol Genet, vol.15, pp.220-226, 2006.

W. E. Tidyman and K. A. Rauen, The RASopathies: developmental syndromes of Ras/ MAPK pathway dysregulation, Curr Opin Genet Dev, vol.19, pp.230-236, 2009.

M. Tartaglia, K. Kalidas, A. Shaw, X. Song, D. L. Musat et al., PTPN11 mutations in Noonan syndrome: molecular spectrum, genotypephenotype correlation, and phenotypic heterogeneity, Am J Hum Genet, vol.70, pp.1555-63, 2002.

M. Tartaglia, S. Martinelli, L. Stella, G. Bocchinfuso, E. Flex et al., Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease, Am J Hum Genet, vol.78, pp.279-90, 2006.

Y. Aoki, T. Niihori, Y. Narumi, S. Kure, and Y. Matsubara, The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders, Hum Mutat, vol.29, pp.992-1006, 2008.

M. Tartaglia, B. D. Gelb, and M. Zenker, Noonan syndrome and clinically related disorders, Best Pract Res Clin Endocrinol Metab, vol.25, pp.161-79, 2011.

K. A. Rauen, S. M. Huson, E. Burkitt-wright, D. G. Evans, S. Farschtschi et al., Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues, Am J Med Genet Part A, vol.167, pp.1-10, 2015.

T. Bardaro, G. Falco, A. Sparago, V. Mercadante, E. G. Molins et al., Two cases of misinterpretation of molecular results in incontinentia pigmenti, and a PCR-based method to discriminate NEMO/IKK? gene deletion, Hum Mutat, vol.21, pp.8-11, 2003.

F. Fusco, M. Paciolla, M. I. Conte, A. Pescatore, E. Esposito et al., Incontinentia pigmenti: report on data from 2000 to 2013, Orphanet J Rare Dis, vol.9, p.93, 2014.

A. D. Ormerod, M. I. White, E. Mckay, and A. W. Johnston, Incontinentia pigmenti in a boy with Klinefelter's syndrome, J Med Genet, vol.24, pp.439-480, 1987.

F. Fusco, T. Bardaro, G. Fimiani, V. Mercadante, M. G. Miano et al., Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-?B activation, Hum Mol Genet, vol.13, pp.1763-73, 2004.

M. I. Conte, A. Pescatore, M. Paciolla, E. Esposito, M. G. Miano et al., Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease, Hum Mutat, vol.35, pp.165-77, 2014.
DOI : 10.1002/humu.22483

S. Mini?, D. Trpinac, and M. Obradovi?, Incontinentia pigmenti diagnostic criteria update, Clin Genet, vol.85, pp.536-578, 2014.

K. Wang, M. Li, and H. Hakonarson, Nucleic Acids Res, vol.38, issue.16, 2010.

D. Salgado, J. P. Desvignes, G. Rai, A. Blanchard, M. Miltgen et al., UMD-predictor: a high-throughput sequencing compliant system for pathogenicity prediction of any human cDNA substitution, Hum Mutat, vol.37, pp.439-485, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01670164

B. Guevara, C. K. Hsu, L. Liu, A. Feast, K. Alabado et al., Improved molecular diagnosis of the common recurrent intragenic deletion mutation in IKBKG in a Filipino family with incontinentia pigmenti, Aust J Dermatol, vol.57, pp.150-153, 2016.

S. Schulz, R. Fröber, C. Kraus, and U. Schneider, Prenatal diagnosis of hypoplastic left heart syndrome associated with Noonan syndrome and de novo RAF1 mutation, Prenat Diagn, vol.32, pp.1016-1024, 2012.

J. M. Ko, J. M. Kim, G. H. Kim, and H. W. Yoo, PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome, J Hum Genet, vol.53, pp.999-1006, 2008.

M. A. Razzaque, T. Nishizawa, Y. Komoike, H. Yagi, M. Furutani et al., Germline gain-of-function mutations in RAF1 cause Noonan syndrome, Nat Genet, vol.39, pp.1013-1020, 2007.

V. Kuburovi?, V. Vukomanovi?, A. Carcavilla, B. Ezquieta-zubicaray, and N. Kuburovi?, Two cases of LEOPARD syndrome-RAF1 mutations firstly described in children, Turk J Pediatr, vol.53, pp.687-91, 2011.

C. Wellbrock, M. Karasarides, and R. Marais, The RAF proteins take Centre stage, Nat Rev Mol Cell Biol, vol.5, pp.875-85, 2004.

M. E. Sana, A. Spitaleri, D. Spiliotopoulos, L. Pezzoli, L. Preda et al., Identification of a novel de novo deletion in RAF1 associated with biventricular hypertrophy in Noonan syndrome, Am J Med Genet Part A, vol.164, pp.2069-73, 2014.

D. Antonelli, J. Antonelli, and T. Rosenfeld, Noonan's syndrome associated with hypoplastic left heart, Cardiology, vol.77, pp.62-67, 1990.

T. Kobayashi, Y. Aoki, T. Niihori, H. Cavé, A. Verloes et al., Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation, Hum Mutat, vol.31, pp.284-94, 2010.

B. Pandit, A. Sarkozy, L. A. Pennacchio, C. Carta, K. Oishi et al., Gainof-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy, Nat Genet, vol.39, p.1007, 2007.

A. W. Kneitel, A. Norby, I. Vettraino, and M. C. Treadwell, A novel mutation on RAF1 in association with fetal findings suggestive of Noonan syndrome, Fetal Pediatr Pathol, vol.34, pp.361-365, 2015.

X. Wu, J. Simpson, J. H. Hong, K. Kim, N. K. Thavarajah et al., MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1 L613V mutation, Differences, vol.121, pp.1009-1034, 2011.

M. Tartaglia and B. D. Gelb, Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms, Ann N Y Acad Sci, vol.1214, pp.99-121, 2010.

I. Young and A. Wilkie, Syndrome of the month, J Med Genet, vol.31, p.744, 1994.

Y. A. Zarate, A. W. Lichty, K. J. Champion, L. K. Clarkson, K. R. Holden et al., Unique cerebrovascular anomalies in Noonan syndrome with RAF1 mutation, J Child Neurol, vol.29, pp.1-6, 2013.

P. Cianci, V. Tono, A. Sala, L. Locatelli, C. Carta et al., A boy with Burkitt lymphoma associated with Noonan syndrome due to a mutation in RAF1, Am J Med Genet A, vol.161, pp.1401-1405, 2013.

B. D. Gelb, A. E. Roberts, and M. Tartaglia, Cardiomyopathies in Noonan syndrome and the other RASopathies, Prog Pediatr Cardiol, vol.39, pp.13-22, 2015.

B. Abdallah, L. C. Lakhoua, Y. Nagara, M. Khiari, K. Elouej et al., A tunisian patient with two rare syndromes: triple a syndrome and congenital hypogonadotropic hypogonadism, Horm Res Paediatr, vol.82, pp.338-381, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-01375104

L. Romdhane, O. Messaoud, Y. Bouyacoub, E. Kerkeni, C. Naouali et al., Comorbidity in the Tunisian population, Clin Genet, vol.89, pp.312-321, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01374974